List of Tables
Table 1. Global Carbapenem Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Carbapenem Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Carbapenem Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Carbapenem Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Carbapenem Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Carbapenem Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Carbapenem Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Carbapenem Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Carbapenem Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carbapenem Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carbapenem Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Carbapenem Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbapenem Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbapenem Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Carbapenem Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Carbapenem Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Carbapenem Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Carbapenem Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Carbapenem Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Carbapenem Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Carbapenem Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Carbapenem Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Carbapenem Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Carbapenem Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Carbapenem Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Carbapenem Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Carbapenem Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Carbapenem Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Carbapenem Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Carbapenem Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Carbapenem Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Carbapenem Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Carbapenem Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Carbapenem Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Carbapenem Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Carbapenem Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Carbapenem Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Carbapenem Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Carbapenem Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Carbapenem Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Carbapenem Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Carbapenem Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Carbapenem Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Carbapenem Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Carbapenem Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Carbapenem Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Carbapenem Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Carbapenem Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Carbapenem Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Carbapenem Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Carbapenem Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Carbapenem Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Carbapenem Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Carbapenem Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Carbapenem Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Carbapenem Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Carbapenem Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Carbapenem Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Carbapenem Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Carbapenem Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Carbapenem Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Carbapenem Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Carbapenem Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Carbapenem Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Carbapenem Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Carbapenem Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Carbapenem Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Shandong New Era Pharmaceutical Company Information
Table 71. Shandong New Era Pharmaceutical Description and Business Overview
Table 72. Shandong New Era Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Shandong New Era Pharmaceutical Carbapenem Drugs Product
Table 74. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 75. Shenzhen Haibin Pharmaceutical Company Information
Table 76. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 77. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product
Table 79. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 80. Sinopharm Guorui Pharmaceutical Company Information
Table 81. Sinopharm Guorui Pharmaceutical Description and Business Overview
Table 82. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product
Table 84. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 85. Taiwan Biotech Co., Ltd. Company Information
Table 86. Taiwan Biotech Co., Ltd. Description and Business Overview
Table 87. Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product
Table 89. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck Carbapenem Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd. Company Information
Table 96. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product
Table 99. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. JW Pharmaceutical Company Information
Table 101. JW Pharmaceutical Description and Business Overview
Table 102. JW Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. JW Pharmaceutical Carbapenem Drugs Product
Table 104. JW Pharmaceutical Recent Developments/Updates
Table 105. Zhengde Pharmaceutical Company Information
Table 106. Zhengde Pharmaceutical Description and Business Overview
Table 107. Zhengde Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Zhengde Pharmaceutical Carbapenem Drugs Product
Table 109. Zhengde Pharmaceutical Recent Developments/Updates
Table 110. Hospira Inc. Company Information
Table 111. Hospira Inc. Description and Business Overview
Table 112. Hospira Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Hospira Inc. Carbapenem Drugs Product
Table 114. Hospira Inc. Recent Developments/Updates
Table 115. WG Critical Care Company Information
Table 116. WG Critical Care Description and Business Overview
Table 117. WG Critical Care Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. WG Critical Care Carbapenem Drugs Product
Table 119. WG Critical Care Recent Developments/Updates
Table 120. Hanhui Pharmaceutical Company Information
Table 121. Hanhui Pharmaceutical Description and Business Overview
Table 122. Hanhui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hanhui Pharmaceutical Carbapenem Drugs Product
Table 124. Hanhui Pharmaceutical Recent Developments/Updates
Table 125. Zhuhai United Laboratories Company Information
Table 126. Zhuhai United Laboratories Description and Business Overview
Table 127. Zhuhai United Laboratories Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhuhai United Laboratories Carbapenem Drugs Product
Table 129. Zhuhai United Laboratories Recent Developments/Updates
Table 130. ACS Dobfar S.p.A Company Information
Table 131. ACS Dobfar S.p.A Description and Business Overview
Table 132. ACS Dobfar S.p.A Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. ACS Dobfar S.p.A Carbapenem Drugs Product
Table 134. ACS Dobfar S.p.A Recent Developments/Updates
Table 135. Iterum Therapeutics plc (ITRM) Company Information
Table 136. Iterum Therapeutics plc (ITRM) Description and Business Overview
Table 137. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product
Table 139. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 140. Daewoong Pharmaceutical Company Information
Table 141. Daewoong Pharmaceutical Description and Business Overview
Table 142. Daewoong Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Daewoong Pharmaceutical Carbapenem Drugs Product
Table 144. Daewoong Pharmaceutical Recent Developments/Updates
Table 145. Aurobindo Pharma Ltd Company Information
Table 146. Aurobindo Pharma Ltd Description and Business Overview
Table 147. Aurobindo Pharma Ltd Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Aurobindo Pharma Ltd Carbapenem Drugs Product
Table 149. Aurobindo Pharma Ltd Recent Developments/Updates
Table 150. Sumitomo Pharma Company Information
Table 151. Sumitomo Pharma Description and Business Overview
Table 152. Sumitomo Pharma Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sumitomo Pharma Carbapenem Drugs Product
Table 154. Sumitomo Pharma Recent Developments/Updates
Table 155. Pfizer Inc. Company Information
Table 156. Pfizer Inc. Description and Business Overview
Table 157. Pfizer Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Pfizer Inc. Carbapenem Drugs Product
Table 159. Pfizer Inc. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Carbapenem Drugs Distributors List
Table 163. Carbapenem Drugs Customers List
Table 164. Carbapenem Drugs Market Trends
Table 165. Carbapenem Drugs Market Drivers
Table 166. Carbapenem Drugs Market Challenges
Table 167. Carbapenem Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Carbapenem Drugs
Figure 2. Global Carbapenem Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Carbapenem Drugs Market Share by Type: 2024 & 2031
Figure 4. Doripenem Product Picture
Figure 5. Ertapenem Product Picture
Figure 6. Imipenem Product Picture
Figure 7. Meropenem Product Picture
Figure 8. Panipenem Product Picture
Figure 9. Biapenem Product Picture
Figure 10. Global Carbapenem Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Carbapenem Drugs Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Carbapenem Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Carbapenem Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Carbapenem Drugs Sales (2020-2031) & (K Units)
Figure 18. Global Carbapenem Drugs Average Price (US$/Unit) & (2020-2031)
Figure 19. Carbapenem Drugs Report Years Considered
Figure 20. Carbapenem Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Carbapenem Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Carbapenem Drugs Players: Market Share by Revenue in Carbapenem Drugs in 2024
Figure 23. Carbapenem Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Carbapenem Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Carbapenem Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Carbapenem Drugs Revenue Market Share by Country (2020-2031)
Figure 27. United States Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Carbapenem Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Carbapenem Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Carbapenem Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Carbapenem Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Carbapenem Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Carbapenem Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Carbapenem Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Carbapenem Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Carbapenem Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Carbapenem Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Carbapenem Drugs by Type (2020-2031)
Figure 57. Global Carbapenem Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Carbapenem Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Carbapenem Drugs by Application (2020-2031)
Figure 60. Global Carbapenem Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Carbapenem Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
